A Retrospective Observational Study to Describe Anaemia Management, Burden of Disease and Outcomes in Chinese Patients on Peritoneal Dialysis Using a Clinical Database

NCT04948424 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2519

Last updated 2022-12-30

No results posted yet for this study

Summary

The overall objective is to describe the epidemiology, health care resource utilisation (HCRU) and selected clinical outcomes in patients initiating PD by anaemia status in real-world setting in China.

Conditions

Sponsors & Collaborators

  • The Second Hospital of Hebei Medical University

    collaborator OTHER
  • Army Medical University, China

    collaborator OTHER
  • The First Affiliated Hospital of Zhengzhou University

    collaborator OTHER
  • Hebei Medical University Third Hospital

    collaborator OTHER
  • Peking University Shenzhen Hospital

    collaborator OTHER
  • Handan Central Hospital, Hebei

    collaborator UNKNOWN
  • Peking Haidian Hospital

    collaborator UNKNOWN
  • People's Hospital of Qinghai Province

    collaborator UNKNOWN
  • Cangzhou Central Hospital

    collaborator OTHER
  • The Second Affiliated Hospital of Harbin Medical University

    collaborator OTHER
  • Shengjing Hospital

    collaborator OTHER
  • The Second Hospital of Anhui Medical University

    collaborator OTHER
  • Peking University People's Hospital

    collaborator OTHER
  • The First Affiliated Hospital of BaoTou Medical College

    collaborator OTHER
  • The People's Hospital of Chuxiong Yi Autonomous Prefecture

    collaborator UNKNOWN
  • Beijing miyun district hospital

    collaborator UNKNOWN
  • Second Hospital of Shanxi Medical University

    collaborator OTHER
  • People's Hospital of Gansu

    collaborator UNKNOWN
  • Pingdingshan first people's Hospital

    collaborator UNKNOWN
  • The first people's hospital of Xining

    collaborator UNKNOWN
  • The First Hospital of Jilin University

    collaborator OTHER
  • Cangzhou People's Hospital

    collaborator OTHER
  • Taiyuan central hospital

    collaborator UNKNOWN
  • People's hospital of Langfang

    collaborator UNKNOWN
  • China Rehabilitation Research Center

    collaborator OTHER_GOV
  • Dongzhimen Hospital, Beijing

    collaborator OTHER
  • Department of Epidemiology and Biostatistics, School of Public Health, Peking University

    collaborator UNKNOWN
  • Peking University First Hospital

    lead OTHER

Principal Investigators

  • Jie Dong · Peking University First Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-08-31
Completion
2022-08-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04948424 on ClinicalTrials.gov